ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

Holden Center At U. Of Iowa Designated Comprehensive.

January 26, 2001

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials

June 4, 1999

Also in this 8-page issue: Senate Labor-HHS finds an extra $1 billion for NIH; Appropriations Committee reports bill to Senate.

July 15, 2005